A prospective, multicentre, randomized, doubleblind, placebocontrolled trial of onabotulinumtoxinA to treat plantarflexor/invertor overactivity after stroke.

http://www.medworm.com/index.php?rid=6339998&cid=c_64_38_f&fid=38076&url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2FPubMed%2F22308557%3Fdopt%3DAbstract

Comments are closed.